We are live on ! Find out more
Axa

Axa Portfolio holdings

AUM $256M
1-Year Est. Return 25.01%
This Fund
S&P 500
This Quarter Est. Return
-3.55%
1 Year Est. Return
+25.01%
3 Year Est. Return
+86.3%
5 Year Est. Return
+113.69%
10 Year Est. Return
+471.75%
AUM
$28.5B
AUM Growth
-$1.64B
Cap. Flow
-$541M
Cap. Flow %
-1.9%
Top 10 Hldgs %
23.41%
Holding
1,182
New
104
Increased
354
Reduced
497
Closed
123

Top Buys

Rank Stock Value
1
AMAT icon
Applied Materials
AMAT
+$94.3M
2
MSFT icon
Microsoft
MSFT
+$65.5M
3
LLY icon
Eli Lilly
LLY
+$58.4M
4
NVDA icon
NVIDIA
NVDA
+$58M
5
ABBV icon
AbbVie
ABBV
+$43.8M

Top Sells

Rank Stock Value
1
SLAB icon
Silicon Laboratories
SLAB
+$84.9M
2
ATVI
Activision Blizzard
ATVI
+$78.4M
3
BAC icon
Bank of America
BAC
+$64.2M
4
MA icon
Mastercard
MA
+$60.4M
5
MMM icon
3M
MMM
+$55.1M

Sector Composition

Rank Sector Weight
1 Technology 33.32%
2 Healthcare 19.18%
3 Consumer Discretionary 12.28%
4 Financials 8.16%
5 Industrials 7.97%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GGB icon
526
Gerdau
GGB
$9.74B
$4.6M 0.02%
1,157,929
-897,715
-44% -$3.99M
DD icon
527
DuPont de Nemours
DD
$18.7B
$4.55M 0.02%
48,578
+421
+0.9% +$39.6K
CERT icon
528
Certara
CERT
$1.21B
$4.5M 0.02%
309,800
-19,900
-6% -$334K
MGPI icon
529
MGP Ingredients
MGPI
$380M
$4.48M 0.02%
42,500
KBH icon
530
KB Home
KBH
$3.45B
$4.45M 0.02%
96,100
+81,500
+558% +$4.14M
REXR icon
531
Rexford Industrial Realty
REXR
$8.56B
$4.44M 0.02%
90,000
VAC icon
532
Marriott Vacations Worldwide
VAC
$3.35B
$4.42M 0.02%
43,900
-15,300
-26% -$1.74M
MMSI icon
533
Merit Medical Systems
MMSI
$4.97B
$4.42M 0.02%
64,000
-1,900
-3% -$137K
BILL icon
534
BILL Holdings
BILL
$4.52B
$4.39M 0.02%
40,417
-4,988
-11% -$567K
SSNC icon
535
SS&C Technologies
SSNC
$18.6B
$4.37M 0.02%
83,179
-5,040
-6% -$288K
COLM icon
536
Columbia Sportswear
COLM
$3.21B
$4.34M 0.02%
58,505
-5,271
-8% -$392K
FANG icon
537
Diamondback Energy
FANG
$56.2B
$4.31M 0.02%
27,848
-14,687
-35% -$2.17M
ENR icon
538
Energizer
ENR
$1.44B
$4.3M 0.02%
+134,200
New +$4.6M
AXS icon
539
AXIS Capital
AXS
$7.67B
$4.28M 0.02%
76,000
-35,900
-32% -$1.98M
RCUS icon
540
Arcus Biosciences
RCUS
$3.55B
$4.27M 0.02%
237,619
+89,450
+60% +$1.8M
DYN icon
541
Dyne Therapeutics
DYN
$4.8B
$4.27M 0.02%
476,026
-1,704
-0.4% -$18.4K
SANM icon
542
Sanmina
SANM
$9.83B
$4.26M 0.02%
78,400
-1,900
-2% -$107K
WTRG icon
543
Essential Utilities
WTRG
$11.4B
$4.24M 0.01%
123,635
-638
-0.5% -$24.7K
DOCS icon
544
Doximity
DOCS
$3.82B
$4.11M 0.01%
193,683
+63,683
+49% +$1.74M
ZLAB icon
545
Zai Lab
ZLAB
$2.06B
$4.1M 0.01%
168,714
-152,330
-47% -$4.06M
CX icon
546
Cemex
CX
$17.2B
$4.07M 0.01%
625,766
-776,322
-55% -$5.76M
BAP icon
547
Credicorp
BAP
$32B
$4.03M 0.01%
31,500
+1,500
+5% +$218K
CLDX icon
548
Celldex Therapeutics
CLDX
$3.02B
$4.01M 0.01%
145,609
+31,479
+28% +$987K
ENOV icon
549
Enovis
ENOV
$1.69B
$4.01M 0.01%
75,957
+3,557
+5% +$207K
DXC icon
550
DXC Technology
DXC
$1.82B
$4M 0.01%
192,000
-226,375
-54% -$5.2M

Similar funds

Axa's Q3 2023 Portfolio in Review

As of Q3 2023, Axa held 1,182 positions worth $28.5B, down 5.5% from $30.1B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Axa's Q3 2023 filing shows 104 new, 354 increased, 497 reduced and 123 closed positions. Its largest new stake was Invesco: 1,126,202 shares worth $16.4M. The largest sale was Silicon Laboratories, an estimated $84.9M.

By sector, the portfolio is most concentrated in Technology at 33% of assets, down from 34% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Axa's largest Q3 2023 buy was Invesco: 1,126,202 shares worth $16.4M.
  • Axa added most to Applied Materials in Q3 2023, an estimated $94.3M increase.
  • Axa's biggest Q3 2023 reduction was Silicon Laboratories, cutting an estimated $84.9M.
  • Axa fully exited Life Storage, Inc. in Q3 2023, selling an estimated $19.3M.
  • Axa's ten largest holdings make up 23% of its $28.5B portfolio in Q3 2023.
  • Axa opened 104 new positions and closed 123 in Q3 2023.
  • Axa's portfolio value fell 5.5% quarter-over-quarter to $28.5B.

Based on Axa's 13F filing for Q3 2023, filed 14 Nov 2023.